title: [Neutron capture therapy in the treatment of glioblastoma multiforme. Initial experience in the Czech Republic].
abstract: BACKGROUND
  Glioblastoma multiforme is the most frequent primary brain tumor in adults. Despite advances in surgery, radiotherapy and chemotherapy, its treatment remains unsatisfactory with very limited overall survival. In the year 2001, in cooperation with Department of Neurosurgery, Nemocnice Na Homolce and Nuclear Research Institute in Rez, we have started to treat glioblastoma patients with boron neutron capture therapy (BNCT).
  
  
  RESULTS
  Cells of malignant brain tumors, especially that of glioblastomas, are able to accumulate boron compounds. If BNCT should be successful, it is necessary to reach selective accumulation of sufficient amount of 10B in the tumor and low accumulation in the normal brain tissue. After BSH administration, radiation with low energy thermal neutrons is delivered. It results in nuclear capture and fission reactions with subsequent selective damage of tumor cells. At the time of analysis 9 patients have been enrolled. Therapy was completed in 5 patients. Treatment has been very well tolerated. We observed minimal acute toxicity associated with radiation and no laboratory abnormalities after administrations of BSH. Unfortunately treatment results were quite unsatisfactory. The median time to progression and overall survival were shorter then expected with conventional treatment.
  
  
  CONCLUSIONS
  BNCT is very well tolerated with only a modest toxicity. In contrast to standard radiation, BNCT patients receive only one dose of radiation. Nevertheless, in this small pilot study first results were inferior when compared either to outcomes of conventional therapy or to results reported from other BNCT groups. It might be explained that lower dose of radiation had been used. Further study will show whether the higher dose radiation can improve treatment results.
authors.affiliation: Onkologická klinika 1. LF UK a VFN, Praha. honova@vfn.cz
authors.forename: H
authors.initials: H
authors.lastname: Honová
authors.forename: M
authors.initials: M
authors.lastname: Safanda
authors.forename: L
authors.initials: L
authors.lastname: Petruzelka
authors.forename: J
authors.initials: J
authors.lastname: Burian
authors.forename: M
authors.initials: M
authors.lastname: Marek
authors.forename: J
authors.initials: J
authors.lastname: Rejchrt
authors.forename: F
authors.initials: F
authors.lastname: Sus
authors.forename: F
authors.initials: F
authors.lastname: Tovarys
authors.forename: V
authors.initials: V
authors.lastname: Dbalý
authors.forename: J
authors.initials: J
authors.lastname: Honzátko
authors.forename: I
authors.initials: I
authors.lastname: Tomandl
authors.forename: V
authors.initials: V
authors.lastname: Mares
mesh_terms: D000328:Adult; D016754:Boron Neutron Capture Therapy / Q000009:adverse effects; D001932:Brain Neoplasms / Q000532:radiotherapy*; D005909:Glioblastoma / Q000532:radiotherapy*; D006801:Humans; D008875:Middle Aged